Who is sponsoring NCT04105673?

NCT04105673 is sponsored by University Hospital, Tours.

What drugs are being tested in NCT04105673?

Interventions in NCT04105673: Clinical examination and survey.

What condition does NCT04105673 study?

NCT04105673 studies Shaken Baby Syndrome.

Is NCT04105673 still recruiting?

NCT04105673 is currently withdrawn. Last updated 26 September 2019.

Last reviewed 2019-09-26 · How we verify

NCT04105673: FPASSBS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Predictors of Sequelae Appearance in Shaken Baby Syndrome

Withdrawn Last updated 26 September 2019

What this trial tests

trial testing Clinical examination and survey in Shaken Baby Syndrome. Withdrawn.

Timeline

28 June 2019

Primary endpoint
28 June 2019

28 June 2019

Quick facts

Lead sponsor	University Hospital, Tours
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	28 June 2019
Primary completion	28 June 2019
Estimated completion	28 June 2019

Drugs / interventions tested

Clinical examination and survey

Conditions studied

Shaken Baby Syndrome — all drugs for Shaken Baby Syndrome →

Sponsor

University Hospital, Tours

Who can join

Adults 5 to 8, any sex, with Shaken Baby Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational, prognostic and prospective study. It is about the Prognostic Factors for sequelae in children with a history of Shaken Baby Syndrome (SBS) in the Central region in France. The study hypothesis is the prognosis of the sequelae children develop according to the severity criteria presents in admission to the hospital for the Shaken Baby Syndrome. The severity criteria are clinical high intracranial pressure, presence of a coma, vitreous hemorrhage, an age under 6 months, other cerebral lesion than subdural hematoma (parenchymal lesion, ischemia or cerebral oedema). Children affected by the nonaccidental head injury are today between five and eight years old.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Tours trials

Trials by the same sponsor.

NCT07452978 — Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence · Phase 2 · not yet recruiting
NCT07443800 — Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia · NA · not yet recruiting
NCT07251530 — Communication Enhancement Among Ventilated Patients in Intensive Care · not yet recruiting
NCT07189338 — Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation · NA · not yet recruiting
NCT07054112 — Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04105673 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Tours
Last refreshed: 26 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04105673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing